ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions.

Atsushi Kawai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.